Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link
Dow Jones Industrial Average
) is trading up 13 points at 16,646 as of Thursday, May 29, 2014, 1:36 p.m. ET. During this time, 115.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 363.5 million. The NYSE advances/declines ratio sits at 1,757 issues advancing vs. 1,207 declining with 183 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a 57-cent gain (+0.7%) bringing the stock to $79.16. This single gain is lifting the Dow Jones Industrial Average by 4.39 points or roughly accounting for 33.8% of the Dow's overall gain. Volume for UnitedHealth Group currently sits at 1.8 million shares traded vs. an average daily trading volume of 4.7 million shares.
UnitedHealth Group has a market cap of $77.52 billion and is part of the health care sector and health services industry. Shares are up 4.4% year-to-date as of Wednesday's close. The stock's dividend yield sits at 1.4%.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States.
TheStreet Ratings rates UnitedHealth Group as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, notable return on equity, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full UnitedHealth Group Ratings Report.